Cargando…
Moderate Binding between Two SARS-CoV-2 Protein Segments and α-Synuclein Alters Its Toxic Oligomerization Propensity Differently
[Image: see text] The neurological symptoms of long COVID and viral neuroinvasion have raised concerns about the potential interactions between SARS-CoV-2 protein segments and neuronal proteins, which might confer a risk of post-infection neurodegeneration, but the underlying mechanisms remain uncle...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662073/ https://www.ncbi.nlm.nih.gov/pubmed/36354180 http://dx.doi.org/10.1021/acs.jpclett.2c02278 |
_version_ | 1784830612620705792 |
---|---|
author | Mesias, Vince St. Dollente Zhu, Hongni Tang, Xiao Dai, Xin Liu, Wei Guo, Yusong Huang, Jinqing |
author_facet | Mesias, Vince St. Dollente Zhu, Hongni Tang, Xiao Dai, Xin Liu, Wei Guo, Yusong Huang, Jinqing |
author_sort | Mesias, Vince St. Dollente |
collection | PubMed |
description | [Image: see text] The neurological symptoms of long COVID and viral neuroinvasion have raised concerns about the potential interactions between SARS-CoV-2 protein segments and neuronal proteins, which might confer a risk of post-infection neurodegeneration, but the underlying mechanisms remain unclear. Here, we reported that the receptor-binding domain (RBD) of the spike protein and the nine-residue segment (SK9) of the envelope protein could bind to α-synuclein (αSyn) with K(d) values of 503 ± 24 nM and 12.7 ± 1.6 μM, respectively. RBD could inhibit αSyn fibrillization by blocking the non-amyloid-β component region and mediating its antiparallel β-sheet structural conversions. Omicron-RBD (BA.5) was shown to have a slightly stronger affinity for αSyn (K(d) = 235 ± 10 nM), which implies similar effects, whereas SK9 may bind to the C-terminus which accelerates the formation of parallel β-sheet-containing oligomers and abruptly increases the rate of membrane disruption by 213%. Our results provide plausible molecular insights into the impact of SARS-CoV-2 post-infection and the oligomerization propensity of αSyn that is associated with Parkinson’s disease. |
format | Online Article Text |
id | pubmed-9662073 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-96620732022-11-14 Moderate Binding between Two SARS-CoV-2 Protein Segments and α-Synuclein Alters Its Toxic Oligomerization Propensity Differently Mesias, Vince St. Dollente Zhu, Hongni Tang, Xiao Dai, Xin Liu, Wei Guo, Yusong Huang, Jinqing J Phys Chem Lett [Image: see text] The neurological symptoms of long COVID and viral neuroinvasion have raised concerns about the potential interactions between SARS-CoV-2 protein segments and neuronal proteins, which might confer a risk of post-infection neurodegeneration, but the underlying mechanisms remain unclear. Here, we reported that the receptor-binding domain (RBD) of the spike protein and the nine-residue segment (SK9) of the envelope protein could bind to α-synuclein (αSyn) with K(d) values of 503 ± 24 nM and 12.7 ± 1.6 μM, respectively. RBD could inhibit αSyn fibrillization by blocking the non-amyloid-β component region and mediating its antiparallel β-sheet structural conversions. Omicron-RBD (BA.5) was shown to have a slightly stronger affinity for αSyn (K(d) = 235 ± 10 nM), which implies similar effects, whereas SK9 may bind to the C-terminus which accelerates the formation of parallel β-sheet-containing oligomers and abruptly increases the rate of membrane disruption by 213%. Our results provide plausible molecular insights into the impact of SARS-CoV-2 post-infection and the oligomerization propensity of αSyn that is associated with Parkinson’s disease. American Chemical Society 2022-11-10 2022-11-17 /pmc/articles/PMC9662073/ /pubmed/36354180 http://dx.doi.org/10.1021/acs.jpclett.2c02278 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Mesias, Vince St. Dollente Zhu, Hongni Tang, Xiao Dai, Xin Liu, Wei Guo, Yusong Huang, Jinqing Moderate Binding between Two SARS-CoV-2 Protein Segments and α-Synuclein Alters Its Toxic Oligomerization Propensity Differently |
title | Moderate Binding
between Two SARS-CoV-2 Protein
Segments and α-Synuclein Alters Its Toxic Oligomerization
Propensity Differently |
title_full | Moderate Binding
between Two SARS-CoV-2 Protein
Segments and α-Synuclein Alters Its Toxic Oligomerization
Propensity Differently |
title_fullStr | Moderate Binding
between Two SARS-CoV-2 Protein
Segments and α-Synuclein Alters Its Toxic Oligomerization
Propensity Differently |
title_full_unstemmed | Moderate Binding
between Two SARS-CoV-2 Protein
Segments and α-Synuclein Alters Its Toxic Oligomerization
Propensity Differently |
title_short | Moderate Binding
between Two SARS-CoV-2 Protein
Segments and α-Synuclein Alters Its Toxic Oligomerization
Propensity Differently |
title_sort | moderate binding
between two sars-cov-2 protein
segments and α-synuclein alters its toxic oligomerization
propensity differently |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662073/ https://www.ncbi.nlm.nih.gov/pubmed/36354180 http://dx.doi.org/10.1021/acs.jpclett.2c02278 |
work_keys_str_mv | AT mesiasvincestdollente moderatebindingbetweentwosarscov2proteinsegmentsandasynucleinaltersitstoxicoligomerizationpropensitydifferently AT zhuhongni moderatebindingbetweentwosarscov2proteinsegmentsandasynucleinaltersitstoxicoligomerizationpropensitydifferently AT tangxiao moderatebindingbetweentwosarscov2proteinsegmentsandasynucleinaltersitstoxicoligomerizationpropensitydifferently AT daixin moderatebindingbetweentwosarscov2proteinsegmentsandasynucleinaltersitstoxicoligomerizationpropensitydifferently AT liuwei moderatebindingbetweentwosarscov2proteinsegmentsandasynucleinaltersitstoxicoligomerizationpropensitydifferently AT guoyusong moderatebindingbetweentwosarscov2proteinsegmentsandasynucleinaltersitstoxicoligomerizationpropensitydifferently AT huangjinqing moderatebindingbetweentwosarscov2proteinsegmentsandasynucleinaltersitstoxicoligomerizationpropensitydifferently |